摘要
Maximising access to and the success of fertility treatments should be a priority for global reproductive health,as should overall patient well-being.The demand for in vitro fertilization(IVF)and other assisted fertility treatments has increased over the past decade and is likely to further increase in years to come.Nevertheless,there is still considerable unmet demand for infertility support worldwide.Moreover,the high emotional,physical and financial burden experienced by individuals undergoing IVF cycles can be a risk for their mental and physical health,which in turn can influence treatment continuation and the likelihood of IVF success.Studies from various parts of the world show that most individuals undergoing IVF also use adjunct alternative medicines and procedures,the most common being traditional Chinese medicine(TCM).The complementary and synergistic role of TCM for individuals undergoing IVF is an area that merits further attention and research,both for its potential positive effects on IVF success rates and for its broader physical and mental health benefits.However,much of the existing evidence is not sufficiently robust or consistent for findings to be adopted with confidence.This commentary argues that much work must be done to understand the efficacy and clinical best practices for these integrated approaches.This can be achieved in part by developing more robust and clinically relevant randomized controlled trial protocols,collecting and triangulating evidence through a variety of study designs and methods,and strengthening the collection and pooling of clinic-level data.
